Additionally, the COX-2 −1195 A→G and −765G→C polymorphisms were demonstrated to influence the expression of COX-2 and confer a risk for developing (adeno)carcinomas in the gastrointestinal tract [15], [38], [39]. Here, PTGS2 is linked to adenocarcinoma.